Why Ginkgo Bioworks Stock Soared Yesterday

Admittedly, this is a clickbait title. Nobody is capable of deciphering why stocks move the way they do which is why hedge funds are now dominated by algorithms with a vociferous appetite for big data. However, we do know two things are true – Ginkgo Bioworks released their 10-K annual report yesterday, and the stock was up +22% on the same day. It’s probably not a coincidence, so let’s sift through the filing and see what insights can be gleaned.

Ginkgo Bioworks 2021 Results

The last time we looked at this synthetic biology darling was in a piece titled Ginkgo Bioworks Responds to Short Seller Report at which time the firm had a market cap of nearly $18 billion. Based on pure Foundry revenues alone, we concluded that shares of Ginkgo Bioworks would need to trade at $2.69 a share or lower before we would consider investing in them. Now that the company’s valuation has dropped 62% over the past four months, and we have new revenue data to work with, we can recalculate the simple valuation ratio t

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.